Dermapharm Holding Balance Sheet Health
Financial Health criteria checks 4/6
Dermapharm Holding has a total shareholder equity of €505.5M and total debt of €601.9M, which brings its debt-to-equity ratio to 119.1%. Its total assets and total liabilities are €1.5B and €945.9M respectively. Dermapharm Holding's EBIT is €265.7M making its interest coverage ratio 38.1. It has cash and short-term investments of €145.9M.
Key information
119.1%
Debt to equity ratio
€601.88m
Debt
Interest coverage ratio | 38.1x |
Cash | €145.88m |
Equity | €505.55m |
Total liabilities | €945.88m |
Total assets | €1.45b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DMPH.F's short term assets (€543.2M) exceed its short term liabilities (€212.1M).
Long Term Liabilities: DMPH.F's short term assets (€543.2M) do not cover its long term liabilities (€733.8M).
Debt to Equity History and Analysis
Debt Level: DMPH.F's net debt to equity ratio (90.2%) is considered high.
Reducing Debt: DMPH.F's debt to equity ratio has reduced from 400.9% to 119.1% over the past 5 years.
Debt Coverage: DMPH.F's debt is well covered by operating cash flow (44.6%).
Interest Coverage: DMPH.F's interest payments on its debt are well covered by EBIT (38.1x coverage).